(Q51973490)

19 April 2018

title

Potent CTL induction by a whole cell pertussis vaccine in anti-tumor peptide immunotherapy. (English)

1 reference

19 April 2018

1 reference

1 reference

Arisa Yano

1

1 reference

19 April 2018

Toshihiro Komatsu

series ordinal

2

1 reference

19 April 2018

Masahide Ishibashi

series ordinal

3

1 reference

19 April 2018

Keiko Udaka

series ordinal

4

1 reference

19 April 2018

publication date

1 January 2007

1 reference

19 April 2018

Microbiology and Immunology

published in

1 reference

19 April 2018

volume

51

1 reference

19 April 2018

issue

7

1 reference

19 April 2018

page(s)

685-699

1 reference

19 April 2018

Cell-mediated immune response of healthy adults to Bordetella pertussis vaccine antigens

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2007.TB03957.X

Help for cytotoxic-T-cell responses is mediated by CD40 signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2007.TB03957.X

IL-2 is required for the activation of memory CD8+ T cells via antigen cross-presentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2007.TB03957.X

Activation of human dendritic cells through CD40 cross-linking.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2007.TB03957.X

Immunization of stage IV melanoma patients with Melan-A/MART-1 and gp100 peptides plus IFN-alpha results in the activation of specific CD8(+) T cells and monocyte/dendritic cell precursors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2007.TB03957.X

Adjuvants and the promotion of Th1-type cytokines in tumour immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2007.TB03957.X

Th1 and Th2 cell clones to a poorly immunogenic tumor antigen initiate CD8+ T cell-dependent tumor eradication in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2007.TB03957.X

Altered peptide ligand vaccination with Flt3 ligand expanded dendritic cells for tumor immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2007.TB03957.X

Pertussis toxin is superior to TLR ligands in enhancing pathogenic autoimmunity, targeted at a neo-self antigen, by triggering robust expansion of Th1 cells and their cytokine production.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2007.TB03957.X

CD4 T cells in tumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2007.TB03957.X

The major histocompatibility complex-restricted antigen receptor on T cells. I. Isolation with a monoclonal antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2007.TB03957.X

T cell receptor antagonist peptides induce positive selection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2007.TB03957.X

Peptides presented to the immune system by the murine class II major histocompatibility complex molecule I-Ad

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2007.TB03957.X

CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2007.TB03957.X

T helper lymphocytes rescue CTL from activation-induced cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2007.TB03957.X

Immunology. Licence to kill

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2007.TB03957.X

Whole-cell Bordetella pertussis vaccine component modulates the mouse immune response to an unrelated soluble antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2007.TB03957.X

Alternative diphtheria, tetanus and whooping cough immunization schedule to evoke a Th2 tetanus and a Th1 pertussis immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2007.TB03957.X

Tumor-specific CD4+ T cells have a major "post-licensing" role in CTL mediated anti-tumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2007.TB03957.X

Immunity to Bordetella pertussis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2007.TB03957.X

Introduction of soluble protein into the class I pathway of antigen processing and presentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2007.TB03957.X

Therapeutic vaccination in patients with gastrointestinal malignancies. A review of immunological and clinical results

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2007.TB03957.X

CD4+ T cells can protect APC from CTL-mediated elimination

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2007.TB03957.X

Reversibility of T helper 1 and 2 populations is lost after long-term stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2007.TB03957.X

Induction by antigen of intrathymic apoptosis of CD4+CD8+TCRlo thymocytes in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2007.TB03957.X

Clinical and immunologic responses to active specific cancer vaccines in human colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2007.TB03957.X

WT1 peptide vaccination combined with BCG-CWS is more efficient for tumor eradication than WT1 peptide vaccination alone

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2007.TB03957.X

Distinct role of antigen-specific T helper type 1 (Th1) and Th2 cells in tumor eradication in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2007.TB03957.X

Induction of WT1 (Wilms' tumor gene)-specific cytotoxic T lymphocytes by WT1 peptide vaccine and the resultant cancer regression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2007.TB03957.X

'Green mice' as a source of ubiquitous green cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2007.TB03957.X

Tumor regression and autoimmunity after reversal of a functionally tolerant state of self-reactive CD8+ T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2007.TB03957.X

Immunization with Melan-A peptide-pulsed peripheral blood mononuclear cells plus recombinant human interleukin-12 induces clinical activity and T-cell responses in advanced melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2007.TB03957.X

PTX cruiser: driving autoimmunity via TLR4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2007.TB03957.X

Laboratory investigation of immune responses to acellular pertussis vaccines when used for boosting adolescents after primary immunisation with whole cell pertussis vaccines: a comparison with data from clinical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2007.TB03957.X

A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2007.TB03957.X

Immunogenicity and protective efficacy of neonatal vaccination against Bordetella pertussis in a murine model: evidence for early control of pertussis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2007.TB03957.X

Monitoring tumor antigen specific T-cell responses in cancer patients and phase I clinical trials of peptide-based vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2007.TB03957.X

Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2007.TB03957.X

Cancer immunotherapy: moving beyond current vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2007.TB03957.X

Distinct T-cell subtypes induced with whole cell and acellular pertussis vaccines in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2007.TB03957.X

T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2007.TB03957.X

Requirement for CD4 T Cell Help in Generating Functional CD8 T Cell Memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2007.TB03957.X

Clinical and immunologic results of a randomized phase II trial of vaccination using four melanoma peptides either administered in granulocyte-macrophage colony-stimulating factor in adjuvant or pulsed on dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2007.TB03957.X

Rapid and strong human CD8+ T cell responses to vaccination with peptide, IFA, and CpG oligodeoxynucleotide 7909.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2007.TB03957.X

Linked foreign T-cell help activates self-reactive CTL and inhibits tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2007.TB03957.X

Collaboration of helper and cytotoxic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2007.TB03957.X

Cutting edge: CD4+ T cell control of CD8+ T cell reactivity to a model tumor antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2007.TB03957.X

Vaccination with mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2007.TB03957.X

Peptide vaccination can lead to enhanced tumor growth through specific T-cell tolerance induction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2007.TB03957.X

Characterization of bactericidal immune responses following vaccination with acellular pertussis vaccines in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2007.TB03957.X

10.1111/J.1348-0421.2007.TB03957.X

21 January 2018

Identifiers

DOI

1 reference

19 April 2018

1 reference

19 April 2018